FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213306566> ?p ?o ?g. }

• W4213306566 abstract "Background In people with acute ischaemic stroke, platelets become activated and can cause blood clots to form and block an artery in the brain, resulting in damage to part of the brain. Such damage gives rise to the symptoms of stroke. Antiplatelet therapy might reduce the volume of brain damaged by ischaemia and also reduce the risk of early recurrent ischaemic stroke, thereby reducing the risk of early death and improving long‐term outcomes in survivors. However, antiplatelet therapy might also increase the risk of fatal or disabling intracranial haemorrhage. Objectives To assess the efficacy and safety of immediate oral antiplatelet therapy (i.e. started as soon as possible and no later than two weeks after stroke onset) in people with acute presumed ischaemic stroke. Search methods We searched the Cochrane Stroke Group Trials Register, CENTRAL, MEDLINE Ovid, Embase Ovid, and two trials registers, and performed forward reference/cited reference searching in August 2020. Selection criteria Randomised controlled trials (RCTs) comparing oral antiplatelet therapy (started within 14 days of the stroke) with control in people with definite or presumed ischaemic stroke. Data collection and analysis Two review authors independently applied the inclusion criteria and assessed trial quality. For the included trials, they extracted and cross‐checked the data. They assessed risk of bias of each study using the Risk of Bias 1 (RoB1) tool and overall certainty of the evidence for each outcome using the GRADE approach. Main results We included 11 studies involving 42,226 participants. Three new trials have been added since the last update (743 participants). As per the previous version of this review, two trials testing aspirin 160 mg to 300 mg once daily, started within 48 hours of onset, contributed 96% of the data. The risk of bias was low. The maximum follow‐up was six months. With treatment, there was a decrease in death or dependency at the end of follow‐up (odds ratio (OR) 0.95, 95% confidence interval (CI) 0.91 to 0.99; 7 RCTs, 42,034 participants; moderate‐certainty evidence). For every 1000 people treated with aspirin, 13 people would avoid death or dependency (number needed to treat for an additional beneficial outcome 79). Authors' conclusions Antiplatelet therapy with aspirin 160 mg to 300 mg daily, given orally (or by nasogastric tube or per rectum in people who cannot swallow) and started within 48 hours of onset of presumed ischaemic stroke, significantly decreased death and dependency, and reduced the risk of early recurrent ischaemic stroke without a major risk of early haemorrhagic complications; long‐term outcomes were improved." @default.
• W4213306566 created "2022-02-24" @default.
• W4213306566 creator A5010546148 @default.
• W4213306566 creator A5027659499 @default.
• W4213306566 creator A5046934477 @default.
• W4213306566 creator A5048845192 @default.
• W4213306566 creator A5048951556 @default.
• W4213306566 creator A5049798132 @default.
• W4213306566 creator A5068076693 @default.
• W4213306566 creator A5079241292 @default.
• W4213306566 date "2022-01-14" @default.
• W4213306566 modified "2023-10-07" @default.
• W4213306566 title "Oral antiplatelet therapy for acute ischaemic stroke" @default.
• W4213306566 cites W1480729244 @default.
• W4213306566 cites W1498265361 @default.
• W4213306566 cites W1573231897 @default.
• W4213306566 cites W175089505 @default.
• W4213306566 cites W186716551 @default.
• W4213306566 cites W1919332000 @default.
• W4213306566 cites W1922501514 @default.
• W4213306566 cites W1929039485 @default.
• W4213306566 cites W1957758434 @default.
• W4213306566 cites W1967517276 @default.
• W4213306566 cites W1971442835 @default.
• W4213306566 cites W1972083038 @default.
• W4213306566 cites W1972215351 @default.
• W4213306566 cites W1972708409 @default.
• W4213306566 cites W1982660761 @default.
• W4213306566 cites W1996802760 @default.
• W4213306566 cites W2001337872 @default.
• W4213306566 cites W2014459583 @default.
• W4213306566 cites W2024352468 @default.
• W4213306566 cites W2026458612 @default.
• W4213306566 cites W2038757076 @default.
• W4213306566 cites W2050856345 @default.
• W4213306566 cites W2057552504 @default.
• W4213306566 cites W2070892802 @default.
• W4213306566 cites W2075862091 @default.
• W4213306566 cites W2078944165 @default.
• W4213306566 cites W2081615170 @default.
• W4213306566 cites W2083716289 @default.
• W4213306566 cites W2089782611 @default.
• W4213306566 cites W2096589566 @default.
• W4213306566 cites W2100089051 @default.
• W4213306566 cites W2122223257 @default.
• W4213306566 cites W2129568225 @default.
• W4213306566 cites W2131499646 @default.
• W4213306566 cites W2158652149 @default.
• W4213306566 cites W2171165037 @default.
• W4213306566 cites W2180717194 @default.
• W4213306566 cites W2186572771 @default.
• W4213306566 cites W2198317276 @default.
• W4213306566 cites W2199144755 @default.
• W4213306566 cites W2292308933 @default.
• W4213306566 cites W2331216347 @default.
• W4213306566 cites W2361921955 @default.
• W4213306566 cites W2409211243 @default.
• W4213306566 cites W2478734695 @default.
• W4213306566 cites W2495479321 @default.
• W4213306566 cites W2696116946 @default.
• W4213306566 cites W2767080640 @default.
• W4213306566 cites W2779726076 @default.
• W4213306566 cites W2804570339 @default.
• W4213306566 cites W2870184972 @default.
• W4213306566 cites W2894622017 @default.
• W4213306566 cites W2944953908 @default.
• W4213306566 cites W2982303713 @default.
• W4213306566 cites W3007596355 @default.
• W4213306566 cites W3015384272 @default.
• W4213306566 cites W3028885010 @default.
• W4213306566 cites W3043492355 @default.
• W4213306566 cites W3092849554 @default.
• W4213306566 cites W3146270511 @default.
• W4213306566 cites W4210248561 @default.
• W4213306566 cites W4210511490 @default.
• W4213306566 cites W4210980547 @default.
• W4213306566 cites W4239471829 @default.
• W4213306566 cites W4245197683 @default.
• W4213306566 cites W4245969404 @default.
• W4213306566 cites W4249374822 @default.
• W4213306566 cites W4290747706 @default.
• W4213306566 cites W4290749263 @default.
• W4213306566 cites W4292022394 @default.
• W4213306566 cites W4298311999 @default.
• W4213306566 cites W4301350706 @default.
• W4213306566 cites W4211200033 @default.
• W4213306566 doi "https://doi.org/10.1002/14651858.cd000029.pub4" @default.
• W4213306566 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35028933" @default.
• W4213306566 hasPublicationYear "2022" @default.
• W4213306566 type Work @default.
• W4213306566 citedByCount "7" @default.
• W4213306566 countsByYear W42133065662022 @default.
• W4213306566 countsByYear W42133065662023 @default.
• W4213306566 crossrefType "journal-article" @default.
• W4213306566 hasAuthorship W4213306566A5010546148 @default.
• W4213306566 hasAuthorship W4213306566A5027659499 @default.
• W4213306566 hasAuthorship W4213306566A5046934477 @default.
• W4213306566 hasAuthorship W4213306566A5048845192 @default.
• W4213306566 hasAuthorship W4213306566A5048951556 @default.
• W4213306566 hasAuthorship W4213306566A5049798132 @default.

• next